ZA201005959B - 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives - Google Patents

4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives

Info

Publication number
ZA201005959B
ZA201005959B ZA2010/05959A ZA201005959A ZA201005959B ZA 201005959 B ZA201005959 B ZA 201005959B ZA 2010/05959 A ZA2010/05959 A ZA 2010/05959A ZA 201005959 A ZA201005959 A ZA 201005959A ZA 201005959 B ZA201005959 B ZA 201005959B
Authority
ZA
South Africa
Prior art keywords
pyrrolo
pyrimidine
pyridine
amine derivatives
amine
Prior art date
Application number
ZA2010/05959A
Other languages
English (en)
Inventor
Thomas J J Mueller
Eugen Merkul
Christian Sirrenberg
Dieter Dorsch
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA201005959B publication Critical patent/ZA201005959B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA2010/05959A 2008-01-22 2010-08-20 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives ZA201005959B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008005493A DE102008005493A1 (de) 2008-01-22 2008-01-22 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
PCT/EP2008/011098 WO2009092431A1 (de) 2008-01-22 2008-12-23 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidin-2-amin-derivative

Publications (1)

Publication Number Publication Date
ZA201005959B true ZA201005959B (en) 2011-04-28

Family

ID=40386204

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/05959A ZA201005959B (en) 2008-01-22 2010-08-20 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives

Country Status (14)

Country Link
US (1) US20100292262A1 (enExample)
EP (1) EP2231664A1 (enExample)
JP (1) JP5524864B2 (enExample)
KR (1) KR20100112626A (enExample)
CN (1) CN101918404A (enExample)
AR (1) AR070212A1 (enExample)
AU (1) AU2008348816B2 (enExample)
BR (1) BRPI0821936A2 (enExample)
CA (1) CA2712612A1 (enExample)
DE (1) DE102008005493A1 (enExample)
IL (1) IL206905A0 (enExample)
MX (1) MX2010007927A (enExample)
WO (1) WO2009092431A1 (enExample)
ZA (1) ZA201005959B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101723936B (zh) * 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
JP2014515368A (ja) 2011-05-26 2014-06-30 第一三共株式会社 プロテインキナーゼ阻害剤としての複素環化合物
BR112015011760B1 (pt) 2012-11-21 2022-12-06 Ptc Therapeutics, Inc Composto, uso do composto, e uso de uma composição farmacêutica
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
JP6524094B2 (ja) 2013-08-30 2019-06-05 ピーティーシー セラピューティクス， インコーポレイテッド 置換ピリミジンＢｍｉ−１阻害剤
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為ＮＩＫ抑制劑的新穎３－（１Ｈ－吡唑－４－基）－１Ｈ－吡咯并［２，３－ｃ］吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作ＮＩＫ抑制劑之新的1-(４-嘧啶基)-１Ｈ-吡唑並[３,２-ｃ]吡啶衍生物
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
KR102499862B1 (ko) 2014-10-23 2023-02-13 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 피라졸 유도체
JP6676048B2 (ja) * 2014-10-23 2020-04-08 ヤンセン ファーマシューティカ エヌ．ベー． Ｎｉｋ阻害剤としての新規化合物
KR102523405B1 (ko) 2014-10-23 2023-04-18 얀센 파마슈티카 엔.브이. Ｎｉｋ 억제제로서의 신규 피라졸로피리미딘 유도체
EP3209670B1 (en) 2014-10-23 2018-10-03 Janssen Pharmaceutica NV New thienopyrimidine derivatives as nik inhibitors
MX2021001870A (es) 2018-08-17 2021-07-15 Ptc Therapeutics Inc Metodo para tratar cancer pancreatico.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
WO2005123672A2 (en) * 2004-06-14 2005-12-29 Takeda San Diego, Inc. Kinase inhibitors
US7855205B2 (en) * 2004-10-29 2010-12-21 Janssen Pharmaceutica Nv Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
CN101801971A (zh) * 2005-09-30 2010-08-11 沃泰克斯药物股份有限公司 可用作janus激酶抑制剂的脱氮嘌呤
DE102006012617A1 (de) * 2006-03-20 2007-09-27 Merck Patent Gmbh 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate

Also Published As

Publication number Publication date
AR070212A1 (es) 2010-03-25
DE102008005493A1 (de) 2009-07-23
CN101918404A (zh) 2010-12-15
MX2010007927A (es) 2010-08-09
KR20100112626A (ko) 2010-10-19
EP2231664A1 (de) 2010-09-29
AU2008348816A1 (en) 2009-07-30
BRPI0821936A2 (pt) 2015-06-16
IL206905A0 (en) 2010-12-30
JP2011510028A (ja) 2011-03-31
CA2712612A1 (en) 2009-07-30
WO2009092431A1 (de) 2009-07-30
JP5524864B2 (ja) 2014-06-18
DE102008005493A8 (de) 2010-03-25
US20100292262A1 (en) 2010-11-18
AU2008348816B2 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
ZA201005959B (en) 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives
IL197393A0 (en) Pyridin-4-yl derivatives as immunomodulating agents
EP2265616B8 (en) Furo-and thieno[3,2-c]pyridines
ZA201003050B (en) [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or pyridin-2-yle derivatives as protein kinase c-theta
ZA201202026B (en) PYROLO[2,3-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
PL2013208T3 (pl) Pirydyno[3,4-B]pirazynowy
PL2069335T3 (pl) Pochodne pirydyn-3-ylu jako środki immunomodulujące
ZA200906736B (en) New 3-([1,2,4] Triazolo [4,3-A]Pyridin-7-YL) Benzamide derivatives
PL2124944T3 (pl) Pochodne pirazolo[3,4-b]pirydyny jako inhibitory fosfodiesterazy
ZA201108885B (en) 3-([1,2,3]triazole-4yl)-pyrrolo[2,3-b]pyridine derivates
IL217798A0 (en) Pyrrolo [1,2-b]pyridazine derivatives as janus kinase inhibitors
PL2155712T3 (pl) 3-(imidazolilo)-pirazolo[3,4-b]pirydyny
IL214426A0 (en) [1,2,4] triazollo [1,5-a] pyridines as kinase inhibitors
ZA201100437B (en) 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors
ZA201101861B (en) Compositions with and process for methylmorpholin-substituted pyrido [2,3-d] pyrimidines
IL207972A0 (en) Pyridin-2-yl derivatives as immunomodulating agents
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
ZA201105257B (en) 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
IL206668A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
GB0714815D0 (en) Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
HK1138515A (en) Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors
HK1160846A (en) [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors